Post — Granola Maple Pecan
by POSTMRT 176 Panel Triggers Identified
Clinical Product Assessment
Post manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 11 MRT-tested substances across multiple food categories including grains, sweeteners, oils, nuts, and spices. The presence of ‘natural flavor’ and specific spices not listed on the MRT 176 panel (cardamom, cloves) introduces additional unknown variables. Due to the high number of potential triggers, this product is unsuitable for the initial phases of the LEAP protocol.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 11
- Safe Ingredients: 1
- Unknown/Ambiguous: 3 (natural flavor, cardamom, cloves)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| whole grain rolled oats | Oat | Direct Match |
| cane sugar | Cane Sugar | Direct Match |
| rice flour | Rice | Direct Match |
| canola oil | Canola/Rapeseed | Direct Match |
| maple syrup | Maple Sugar | Direct Match |
| pecans | Pecan | Direct Match |
| barley malt extract | Barley, Malt | Direct Match |
| cinnamon | Cinnamon | Direct Match |
| ginger | Ginger | Direct Match |
| pepper | Black Pepper | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: natural flavor, cardamom, cloves. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 11 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 884912294081
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Oat is independently tested on the MRT panel. Found in oatmeal, granola, and many "gluten-free" products that use oat flour. Distinct from wheat sensitivity.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Rice is often used as a "safe" base in elimination diets, but some patients do react to it. Verify with your MRT results before assuming rice is safe for your Phase 1 rotation.
Canola oil (derived from rapeseed) is an MRT-tested substance. It is one of the most common cooking oils in processed foods and restaurant cooking. Look for it in fried foods, dressings, and baked goods.
Cinnamon is tested on the MRT panel. Found in baked goods, cereals, spice blends, and flavored beverages. Contains coumarin, which is also separately tested on the chemical panel.
Black pepper (Piper nigrum) is tested on the MRT panel. One of the most ubiquitous spices worldwide — found in virtually every seasoned or prepared food. Often hidden under "spices" on labels.
What This Means For Your Diet
With 11 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 11 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from POST
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners